152 related articles for article (PubMed ID: 29656661)
1. High Oct4 predicted worse prognosis of right-sided colon cancer patients.
Wang QH; Zhang M; Shi CT; Xie JJ; Chen F; Shi QF; Cheng J; Wang HN
Future Oncol; 2018 Sep; 14(22):2279-2291. PubMed ID: 29656661
[TBL] [Abstract][Full Text] [Related]
2. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
Hu J; Li J; Yue X; Wang J; Liu J; Sun L; Kong D
Oncotarget; 2017 Apr; 8(17):28463-28470. PubMed ID: 28212529
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
Lim DR; Kuk JK; Kim T; Shin EJ
Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
[TBL] [Abstract][Full Text] [Related]
6. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
7. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.
Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG
Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772
[TBL] [Abstract][Full Text] [Related]
8. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.
Yahagi M; Okabayashi K; Hasegawa H; Tsuruta M; Kitagawa Y
J Gastrointest Surg; 2016 Mar; 20(3):648-55. PubMed ID: 26573851
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
[TBL] [Abstract][Full Text] [Related]
10. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
11. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinicopathological and survival features of right and left colon cancers.
Helvaci K; Eraslan E; Yildiz F; Tufan G; Demirci U; Berna Oksuzoglu O; Yalcintas Arslan U
J BUON; 2019; 24(5):1845-1851. PubMed ID: 31786846
[TBL] [Abstract][Full Text] [Related]
15. Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer.
Narayanan S; Gabriel E; Attwood K; Boland P; Nurkin S
Clin Colorectal Cancer; 2018 Dec; 17(4):e671-e678. PubMed ID: 30108021
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-3658 down-regulates OCT4 gene expression followed by suppressing SW480 cell proliferation and migration.
Hosseini F; Soltani BM; Baharvand H; Hosseinkhani S
Biochem J; 2020 Jun; 477(12):2281-2293. PubMed ID: 32478824
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolomic profiling distinguishes right-sided from left-sided colon cancer.
Deng K; Han P; Song W; Wang Z; Zhang F; Xie H; Zhao W; Xu H; Cai Y; Rong Z; Yu X; Cui BB; Li K
Clin Chim Acta; 2018 Dec; 487():357-362. PubMed ID: 30296444
[TBL] [Abstract][Full Text] [Related]
19. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract][Full Text] [Related]
20. Better survival of right-sided than left-sided stage II colon cancer: a propensity scores matching analysis based on SEER database.
Wang S; Xu X; Guan J; Huo R; Liu M; Jiang C; Wang W
Turk J Gastroenterol; 2020 Nov; 31(11):805-813. PubMed ID: 33361044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
